Source: Chicago Tribune
By Bruce Japsen
Tribune staff reporter
Published March 7, 2006
A treatment that uses adult stem cells to rebuild failing hearts--once believed to be impossible--will undergo a pivotal test starting this week in a 150-patient clinical trial under the watch of Baxter International Inc.
No comments:
Post a Comment